PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) (the "Company" or "PetVivo") an emerging biomedical device company focused on the commercialization ...

PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it ...

Atrazine has been tied to higher risks of disrupted hormone levels and reproductive issues, as well as liver, kidney and ...

The single-use blood lancing device is intended to produce microliter capillary whole-blood samples and provide an alternative to finger-prick blood draws. It produces a blood volume of up to 600 ul ...

This is a game changer for veterinarians and their ability to treat their patients with PRP”, said Mike Eldred, PetVivo Board Member. “This innovative, and FDA reviewed product, will be a great ...

The white-cell count was 8680 per microliter (reference range, 3900 to 11,000), and the eosinophil count was 870 per microliter (reference range, 0 to 450); laboratory test results are shown in ...

"Earlier laboratory tests often used high initial concentrations and volumes of αHAs in the hundreds-of-millimolar or microliter range, respectively, which may not reflect the conditions on ...